Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Deciphera Pharmaceuticals Inc (DCPH)

Deciphera Pharmaceuticals Inc (DCPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,149,784
  • Shares Outstanding, K 80,800
  • Annual Sales, $ 163,360 K
  • Annual Income, $ -194,940 K
  • 60-Month Beta 0.39
  • Price/Sales 7.28
  • Price/Cash Flow N/A
  • Price/Book 3.39
Trade DCPH with:

Options Overview Details

View History
  • Implied Volatility 111.12% ( +10.38%)
  • Historical Volatility 36.03%
  • IV Percentile 92%
  • IV Rank 66.95%
  • IV High 154.28% on 02/02/24
  • IV Low 23.70% on 10/17/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 282
  • Volume Avg (30-Day) 36
  • Put/Call OI Ratio 1.25
  • Today's Open Interest 565
  • Open Int (30-Day) 551

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.55
  • Number of Estimates 7
  • High Estimate -0.46
  • Low Estimate -0.63
  • Prior Year -0.60
  • Growth Rate Est. (year over year) +8.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.08 +1.70%
on 04/19/24
16.17 -11.44%
on 03/28/24
-0.65 (-4.34%)
since 03/19/24
3-Month
13.50 +6.07%
on 01/22/24
17.73 -19.23%
on 03/01/24
+0.74 (+5.45%)
since 01/19/24
52-Week
9.90 +44.65%
on 10/25/23
17.73 -19.23%
on 03/01/24
-1.04 (-6.77%)
since 04/19/23

Most Recent Stories

More News
Medison Pharma Announces Public Formulary Listing of QINLOCK® (ripretinib) in Canadian Provinces: Ontario and Quebec for Advanced Gastrointestinal Stromal Tumor (GIST) Treatment

/PRNewswire/ -- Today, Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies to patients in...

DCPH : 14.36 (+0.91%)
Medison Pharma Announces Public Formulary Listing of QINLOCK® (ripretinib) in Canadian Provinces: Ontario and Quebec for Advanced Gastrointestinal Stromal Tumor (GIST) Treatment

/CNW/ -- Today, Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies to patients in international...

DCPH : 14.36 (+0.91%)
3 Under-the-Radar Biotech Stocks to Buy in 2023

All three biotech companies focus on oncology therapies.

DCPH : 14.36 (+0.91%)
MRTX : 58.70 (-0.17%)
MGNX : 15.49 (-3.61%)
Why Shares of Deciphera Pharmaceuticals Rose This Week

The company's shares rose after the company reported second-quarter earnings.

DCPH : 14.36 (+0.91%)
Deciphera Pharmaceuticals to Present at the JMP Securities Life Sciences Conference

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today...

DCPH : 14.36 (+0.91%)
Deciphera (DCPH) Q1 Earnings Match Estimates, Sales Miss

Deciphera Pharmaceuticals (DCPH) reports mixed first-quarter 2023 results as its earnings are in line with the Zacks Consensus Estimate, while revenues miss the same.

PFE : 25.80 (+1.61%)
ADMA : 6.20 (unch)
DCPH : 14.36 (+0.91%)
APTX : 0.0960 (+3.11%)
Deciphera Pharmaceuticals, Inc. (DCPH) Reports Q1 Loss, Lags Revenue Estimates

Deciphera Pharmaceuticals, Inc. (DCPH) delivered earnings and revenue surprises of 0% and 5.10%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

DCPH : 14.36 (+0.91%)
CRIS : 14.29 (-6.11%)
Deciphera Pharmaceuticals Announces First Quarter 2023 Financial Results

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today...

DCPH : 14.36 (+0.91%)
Deciphera Pharmaceuticals to Announce First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 3, 2023

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today...

DCPH : 14.36 (+0.91%)
Deciphera Pharmaceuticals to Present at the Stifel Virtual Targeted Oncology Days

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today...

DCPH : 14.36 (+0.91%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Deciphera Pharmaceuticals, Inc. develops small molecule kinase inhibitors for cancer, utilizing its proprietary kinase switch control inhibitor platform.

See More

Key Turning Points

3rd Resistance Point 15.42
2nd Resistance Point 15.16
1st Resistance Point 14.70
Last Price 14.36
1st Support Level 13.98
2nd Support Level 13.72
3rd Support Level 13.26

See More

52-Week High 17.73
Fibonacci 61.8% 14.74
Last Price 14.36
Fibonacci 50% 13.81
Fibonacci 38.2% 12.89
52-Week Low 9.90

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar